down arrow

ResMed, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7611521078
USD
251.51
0.07 (0.03%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,347.99
1,291.74
1,282.09
1,224.51
1,223.19
1,196.98
1,162.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,347.99
1,291.74
1,282.09
1,224.51
1,223.19
1,196.98
1,162.80
Raw Material Cost
539.85
536.22
541.86
518.69
518.93
515.40
527.44
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
4.79
5.50
9.55
14.38
13.80
Selling and Distribution Expenses
265.12
245.30
241.61
238.98
242.19
229.92
222.16
Other Expenses
8.64
8.39
7.66
7.40
7.13
6.27
6.01
Total Expenditure (Excl Depreciation)
891.42
865.47
864.85
837.20
841.98
822.40
823.48
Operating Profit (PBDIT) excl Other Income
456.59999999999997
426.3
417.2
387.29999999999995
381.2
374.6
339.3
Other Income
-0.44
-8.57
1.43
0.29
-14.68
14.92
-1.83
Operating Profit (PBDIT)
530.42
469.60
474.57
441.32
421.29
444.15
390.86
Interest
0.00
0.00
4.79
5.50
9.55
14.38
13.80
Exceptional Items
1.92
0.00
4.44
1.39
0.75
0.29
-64.23
Gross Profit (PBDT)
808.14
755.51
740.23
705.82
704.26
681.58
635.36
Depreciation
74.29
51.91
55.90
53.71
54.75
54.64
53.37
Profit Before Tax
458.05
417.69
418.32
383.50
357.73
375.42
259.45
Tax
78.35
52.65
73.70
72.14
65.50
74.93
50.65
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
379.70
365.04
344.62
311.36
292.24
300.49
208.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
379.70
365.04
344.62
311.36
292.24
300.49
208.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
379.70
365.04
344.62
311.36
292.24
300.49
208.80
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
5,967.86
5,546.13
5,253.01
5,195.03
4,864.04
4,629.92
4,481.85
Earnings per share (EPS)
2.58
2.48
2.34
2.11
1.98
2.04
1.42
Diluted Earnings per share
2.58
2.48
2.34
2.11
1.98
2.04
1.42
Operating Profit Margin (Excl OI)
33.87%
33.0%
32.54%
31.63%
31.17%
31.29%
29.18%
Gross Profit Margin
39.49%
36.35%
36.99%
35.7%
33.72%
35.93%
26.9%
PAT Margin
28.17%
28.26%
26.88%
25.43%
23.89%
25.1%
17.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 10.20% vs 9.01% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 29.95% vs 27.21% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 21.77% vs 27.71% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is -100.00% vs -62.35% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of ResMed, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,347.99
1,012.45
335.54
33.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,347.99
1,012.45
335.54
33.14%
Raw Material Cost
539.85
296.36
243.49
82.16%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
265.12
448.69
-183.57
-40.91%
Other Expenses
8.64
9.64
-1.00
-10.37%
Total Expenditure (Excl Depreciation)
891.42
841.45
49.97
5.94%
Operating Profit (PBDIT) excl Other Income
456.57
171.00
285.57
167.00%
Other Income
-0.44
37.58
-38.02
-101.17%
Operating Profit (PBDIT)
530.42
241.19
289.23
119.92%
Interest
0.00
0.00
0.00
Exceptional Items
1.92
-27.10
29.02
107.08%
Gross Profit (PBDT)
808.14
716.09
92.05
12.85%
Depreciation
74.29
40.58
33.71
83.07%
Profit Before Tax
458.05
173.52
284.53
163.98%
Tax
78.35
48.91
29.44
60.19%
Provisions and contingencies
0
0
0.00
Profit After Tax
379.70
124.61
255.09
204.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
379.70
124.61
255.09
204.71%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
379.70
124.61
255.09
204.71%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
5,967.86
3,912.78
2,055.08
52.52%
Earnings per share (EPS)
2.58
1.72
0.86
50.00%
Diluted Earnings per share
2.58
1.72
0.86
50.00%
Operating Profit Margin (Excl OI)
33.87%
16.10%
0.00
17.77%
Gross Profit Margin
39.49%
21.15%
0.00
18.34%
PAT Margin
28.17%
12.31%
0.00
15.86%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 134.80 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.36% vs 0.75% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 10.20% vs 9.01% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 37.97 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.03% vs 5.92% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 29.95% vs 27.21% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 53.09 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 11.02% vs 1.08% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 21.77% vs 27.71% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.87%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."